JH. Van Tyle, Ketoconazole. Mechanism of action, spectrum of activity, pharmacokinetics, drug interactions, adverse reactions and therapeutic use., in Pharmacotherapy, vol. 4, n. 6, Nov-Dic 1984, pp. 343-73, PMID6151171.
JW. Van Der Meer, JJ. Keuning; HW. Scheijgrond; J. Heykants; J. Van Cutsem; J. Brugmans, The influence of gastric acidity on the bio-availability of ketoconazole., in J Antimicrob Chemother, vol. 6, n. 4, Lug 1980, pp. 552-4, PMID6253434.
P. Lelawongs, JA. Barone; JL. Colaizzi; AT. Hsuan; W. Mechlinski; R. Legendre; J. Guarnieri, Effect of food and gastric acidity on absorption of orally administered ketoconazole., in Clin Pharm, vol. 7, n. 3, marzo 1988, pp. 228-35, PMID3356120.
D. Greenspan, Treatment of oropharyngeal candidiasis in HIV-positive patients., in J Am Acad Dermatol, vol. 31, 3 Pt 2, settembre 1994, pp. S51-5, PMID7915732.
SE. Reef, WC. Levine; MM. McNeil; S. Fisher-Hoch; SD. Holmberg; A. Duerr; D. Smith; JD. Sobel; RW. Pinner, Treatment options for vulvovaginal candidiasis, 1993., in Clin Infect Dis, 20 Suppl 1, aprile 1995, pp. S80-90, PMID7795112.
R. Negroni, AM. Robles; A. Arechavala; MA. Tuculet; R. Galimberti, Ketoconazole in the treatment of paracoccidioidomycosis and histoplasmosis., in Rev Infect Dis, vol. 2, n. 4, pp. 643-9, PMID6255544.
DT. Roberts, NH. Cox; JC. Gentles; KK. Babu, Comparison of ketoconazole and griseofulvin in the treatment of tinea pedis., in J Med Vet Mycol, vol. 25, n. 5, Ott 1987, pp. 347-50, PMID3430295.
D. Greer, HW. Jolly, Comparative trial of a two-dosage schedule of ketoconazole 2% cream for the treatment of tinea pedis., in J Am Acad Dermatol, vol. 17, n. 1, luglio 1987, pp. 53-6, PMID3301923.
DW. Schneck, Therapeutic rounds. Ketoconazole in the treatment of tinea corporis., in Clin Ther, vol. 6, n. 1, 1983, pp. 17, 103, PMID6325004.
JN. Galgiani, Ketoconazole in the treatment of coccidioidomycosis., in Drugs, vol. 26, n. 4, ottobre 1983, pp. 355-63, PMID6313321.
A. Restrepo, I. Gómez; LE. Cano; MD. Arango; F. Gutiérrez; A. Sanín; MA. Robledo, Treatment of paracoccidioidomycosis with ketoconazole: a three-year experience., in Am J Med, vol. 74, 1B, gennaio 1983, pp. 48-52, PMID6295151.
A. Restrepo, I. Gómez; MA. Robledo, [Efficacy of ketoconazole in patients with recurrent paracoccidioidomycosis]., in Rev Inst Med Trop Sao Paulo, vol. 24, n. 3, pp. 173-9, PMID6296983.
SJ. Jubelirer, T. Hogan, High dose ketoconazole for the treatment of hormone refractory metastatic prostate carcinoma: 16 cases and review of the literature., in J Urol, vol. 142, n. 1, luglio 1989, pp. 89-91, PMID2659829.
C. Mahler, J. Verhelst; L. Denis, Ketoconazole and liarozole in the treatment of advanced prostatic cancer., in Cancer, vol. 71, 3 Suppl, febbraio 1993, pp. 1068-73, PMID8428329.
CS. Brusko, JT. Marten, Ketoconazole hepatotoxicity in a patient treated for environmental illness and systemic candidiasis., in DICP, vol. 25, n. 12, dicembre 1991, pp. 1321-5, PMID1815425.
A. Svedhem, Toxic hepatitis following ketoconazole treatment., in Scand J Infect Dis, vol. 16, n. 1, 1984, pp. 123-5, PMID6320358.
PA. Duarte, CC. Chow; F. Simmons; J. Ruskin, Fatal hepatitis associated with ketoconazole therapy., in Arch Intern Med, vol. 144, n. 5, maggio 1984, pp. 1069-70, PMID6324708.
TE. Knight, CY. Shikuma; J. Knight, Ketoconazole-induced fulminant hepatitis necessitating liver transplantation., in J Am Acad Dermatol, vol. 25, 2 Pt 2, agosto 1991, pp. 398-400, PMID1832694.
EP. Van Puijenbroek, HJ. Metselaar; PH. Berghuis; PE. Zondervan; BH. Stricker, [Acute hepatocytic necrosis during ketoconazole therapy for treatment of onychomycosis. National Foundation for Registry and Evaluation of Adverse Effects]., in Ned Tijdschr Geneeskd, vol. 142, n. 44, ottobre 1998, pp. 2416-8, PMID9864540.
web.archive.org
Copia archiviata (PDF), su farmacovigilanza.asl3.liguria.it. URL consultato il 3 gennaio 2019 (archiviato dall'url originale il 20 ottobre 2016).